Skip to main content
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: Kidney Int. 2022 Apr 20;101(6):1126–1141. doi: 10.1016/j.kint.2022.03.019

Figure 2. GWAS, Exome, or Genome Sequencing Studies. 13, 14, 17, 19, 31, 39-41.

Figure 2.

*The largest study focused on urinary albumin-to-creatinine ratio. Several included serum albumin studies.

**Pediatric population.

***For case-control studies, the total sample sizes were plotted.

CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate; FSGS, focal segmental glomerulosclerosis; GWAS, genome-wide association studies; IgAN, IgA nephropathy; KF, kidney failure; LN, lupus nephritis; MCD, minimal change disease; MN, membranous nephropathy; Scr, serum creatinine; SRNS and SSNS, steroid-resistant and steroid-sensitive nephrotic syndrome; T1DM and T2DM, types 1 and 2 diabetes mellitus; WES, whole exome sequencing; WGS, whole genome sequencing.